Showing results (281-290 of 541) with videos related to
Sort By:
Pageof 55
Drugs - Real World Outcomes|May 11, 2019
A Benefit Risk Review of Pediatric Use of Hydrocodone/Chlorpheniramine, a Prescription Opioid Antitussive Agent for the Treatment of CoughVictor S Sloan, Alphia Jones, Chidi Maduka, et al.Drugs - Real World Outcomes|September 9, 2018
Inappropriate Prescribing in Elderly Inpatients at a University Hospital in Saudi ArabiaNisreen Abdulrahman Jastaniah, Ahmed Saeed Almaqati, Anas Khaleel Alsuraihi, et al.Drugs - Real World Outcomes|March 22, 2022
Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate CancerMarscha S Holleman, Simone A Huygens, Maiwenn J Al, et al.Drugs - Real World Outcomes|March 19, 2022
Context and Considerations for Use of Two Japanese Real-World Databases in Japan: Medical Data Vision and Japanese Medical Data CenterThomas Laurent, Jason Simeone, Ryohei Kuwatsuru, et al.Drugs - Real World Outcomes|May 5, 2018
Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System DatabaseTadashi Toki, Shunsuke OnoDrugs - Real World Outcomes|September 2, 2025
Tyrosine Kinase Inhibitors and Interstitial Lung Disease: A Disproportionality Analysis Using the European Post-marketing EudraVigilance DatabaseDevron R Shah, Simon P Hart, Dominic L SykesDrugs - Real World Outcomes|May 19, 2017
Risk of Hip Fracture in Older People Using Selective Serotonin Reuptake Inhibitors and Other Psychoactive Medicines Concurrently: A Matched Case-Control Study in AustraliaMichael J Leach, Nicole L Pratt, Elizabeth E RougheadDrugs - Real World Outcomes|June 11, 2017
Central and Peripheral Nervous System Disorders Following Ivermectin Mass Administration: A Descriptive Study Based on the Democratic Republic of Congo Pharmacovigilance SystemDidier Nzolo, Francis Anto, Sarah Hailemariam, et al.Drugs - Real World Outcomes|April 27, 2023
Post-Marketing Safety Study of Ramucirumab Plus FOLFIRI: Analysis of Age and Initial Dose of Irinotecan in Patients with Metastatic Colorectal CancerToshiki Masuishi, Soshi Nagaoka, Long Jin, et al.Drugs - Real World Outcomes|July 11, 2020
Intravenous Lidocaine for Acute Pain: A Single-Institution Retrospective StudyKyle De Oliveira, Naveen EipePageof 55